These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6122288)

  • 41. [Cardiovascular effects of timolol, carteolol, metipranolol, betaxolol collyres in the aged patient].
    Le Jeunne C; Bringer L; Mondjee-Tahura Z; Munera Y; Hugues FC
    Therapie; 1988; 43(2):89-92. PubMed ID: 2900562
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of Ramadan fasting on platelet aggregation in healthy male subjects.
    Aybak M; Türkoğlu A; Sermet A; Denli O
    Eur J Appl Physiol Occup Physiol; 1996; 73(6):552-6. PubMed ID: 8817126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of hydroxyethyl starch on platelet aggregation in vitro.
    Blaicher AM; Reiter WJ; Blaicher W; Kettner SC; Felfernig M; Grabner CM; Zimpfer M
    Anesth Analg; 1998 Jun; 86(6):1318-21. PubMed ID: 9620527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of nifedipine on platelet function.
    Takahara K; Kuroiwa A; Matsushima T; Nakashima Y; Takasugi M
    Am Heart J; 1985 Jan; 109(1):4-8. PubMed ID: 3155583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet dysfunction in essential thrombocythaemia.
    Stathakis NE; Papayannis AG; Arapakis G; Gardikas C
    Ann Clin Res; 1974 Aug; 6(4):198-202. PubMed ID: 4473953
    [No Abstract]   [Full Text] [Related]  

  • 48. Systemic effects of carteolol, a beta-adrenoceptor antagonist in stroke-prone spontaneously hypertensive rats.
    Yamashita K; Ohta H; Uchida S; Shigematsu K; Ohkubo T; Niwa M; Ozaki M
    J Pharmacobiodyn; 1990 Jan; 13(1):64-9. PubMed ID: 1971305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood hyperviscosity in psoriasis.
    Wolf R; Machtey I; Feuerman EJ; Creter D
    Acta Derm Venereol; 1981; 61(2):153-4. PubMed ID: 6165194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of ticlopidine of platelet function in men with stable angina pectoris.
    Berglund U; von Schenck H; Wallentin L
    Thromb Haemost; 1985 Dec; 54(4):808-12. PubMed ID: 3911481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of antioxidant nutrients on platelet function in healthy volunteers.
    Calzada C; Bruckdorfer KR; Rice-Evans CA
    Atherosclerosis; 1997 Jan; 128(1):97-105. PubMed ID: 9051202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertension.
    Lande K; Kjeldsen SE; Os I; Westheim A; Hjermann I; Eide I; Gjesdal K
    J Hypertens; 1988 Mar; 6(3):219-25. PubMed ID: 2966193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet function and fibrinolytic activity in hypertension: differential effects of calcium antagonists and beta-adrenergic receptor blockers.
    Winther K; Gleerup G; Hedner T
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S41-4. PubMed ID: 1725542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An unclassified platelet function disorder associated with bleeding tendency.
    Endo Y; Mamiya S; Niitsu H; Iwamoto K; Hamanaka S; Miura AB
    Tohoku J Exp Med; 1987 Apr; 151(4):387-94. PubMed ID: 2956728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet activity and selective beta-blockade in migraine prophylaxis.
    Joseph R; Steiner TJ; Schultz LU; Clifford Rose F
    Stroke; 1988 Jun; 19(6):704-8. PubMed ID: 2897733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of suloctidil on bleeding time and in vivo platelet aggregation in rats.
    de Gaetano G; Cavenaghi AE
    Thromb Res; 1977 Mar; 10(3):525-30. PubMed ID: 854885
    [No Abstract]   [Full Text] [Related]  

  • 57. Beta 2-adrenoceptor-mediated intrinsic sympathomimetic activity of carteolol: an in vivo study.
    Bruck H; Poller U; Lüssenhop H; Pönicke K; Temme T; Heusch G; Philipp T; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):361-8. PubMed ID: 15526107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelet function in blood from the coronary sinus in patients with arteriosclerotic heart disease.
    Thaulow E
    Thromb Haemost; 1983 Oct; 50(3):629-32. PubMed ID: 6228029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Partial agonistic effects of carteolol on atypical beta-adrenoceptors in the guinea pig gastric fundus.
    Horinouchi T; Koike K
    Jpn J Pharmacol; 2000 Nov; 84(3):287-92. PubMed ID: 11138729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pharmacodynamics of carteolol].
    Odenthal KP
    Arzneimittelforschung; 1983; 33(2a):281-5. PubMed ID: 6132609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.